Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group
Satrajit Roychoudhury, Keaven M Anderson, Jiabu Ye, and Pralay, Mukhopadhyay

TL;DR
This paper offers a robust approach for designing and analyzing clinical trials with non-proportional hazards, proposing a combination test to maintain power across various scenarios, supported by real examples and simulations.
Contribution
It introduces a combination test method for clinical trial analysis under non-proportional hazards, enhancing robustness and interpretability over traditional methods.
Findings
Combination test maintains power across different non-proportional hazard scenarios.
Design and analysis strategies are illustrated with real-life examples.
Simulation results demonstrate improved robustness of the proposed approach.
Abstract
Loss of power and clear description of treatment differences are key issues in designing and analyzing a clinical trial where non-proportional hazard is a possibility. A log-rank test may be very inefficient and interpretation of the hazard ratio estimated using Cox regression is potentially problematic. In this case, the current ICH E9 (R1) addendum would suggest designing a trial with a clinically relevant estimand, e.g., expected life gain. This approach considers appropriate analysis methods for supporting the chosen estimand. However, such an approach is case specific and may suffer lack of power for important choices of the underlying alternate hypothesis distribution. On the other hand, there may be a desire to have robust power under different deviations from proportional hazards. Also, we would contend that no single number adequately describes treatment effect under…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Pharmaceutical Economics and Policy · Health Systems, Economic Evaluations, Quality of Life
